Table 3.
Univariate analysisa |
Multivariate analysis |
|||
---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Age, years | 1.02 (0.98, 1.07) | 0.382 | ||
Male | 1.08 (0.60, 1.95) | 0.787 | ||
Statins | 0.34 (0.17, 0.68) | 0.002 | 0.28 (0.13, 0.62) | 0.002 |
Infection at other sites | 5.37 (1.25, 23.13) | 0.024 | ||
SBP, mmHg | 0.99 (0.97, 1.01) | 0.090 | ||
DBP, mmHg | 0.98 (0.95, 1.01) | 0.089 | ||
Laboratory tests | ||||
Albumin, g/dL | 0.88 (0.82, 0.94) | <0.001 | 0.91 (0.85, 0.98) | 0.013 |
T Bil, μmol/L | 1.02 (1.00, 1.03) | 0.039 | ||
TG, mmol/L | 2.13 (1.41, 3.22) | <0.001 | 2.29 (1.48, 3.55) | <0.001 |
TC, mmol/L | 1.07 (0.82, 1.4) | 0.612 | ||
Thrombin time, s | 1.12 (1.01, 1.24) | 0.033 | 1.16 (1.02, 1.30) | 0.018 |
CRP, mg/L | 1.01 (1.00, 1.01) | 0.017 | 1.01 (0.99, 1.01) | 0.096 |
Comorbidities | ||||
COPD | 1.88 (1.04, 3.42) | 0.038 | 2.23 (1.12, 4.45) | 0.022 |
Chronic heart failure | 2.59 (1.26, 5.32) | 0.009 | 3.07 (1.31, 7.20) | 0.010 |
Preadmission medication | ||||
Aspirin | 0.46 (0.21, 0.99) | 0.047 | ||
Spironolactone | 2.82 (1.27, 6.25) | 0.011 | ||
Digoxin | 2.56 (1.06, 6.17) | 0.036 |
Abbreviations: OR, odds ratio; CI, confidence interval; T Bil, total bilirubin; TG, tryglycerides; CRP, C-reactive protein; COPD, chronic obstructive pulmonary disease; SBP, systolic blood pressure; DBP diastolic blood pressure; TC, total cholesterol.
Logistic regression was implemented, and a backward procedure was applied to a multivariate analysis model (R2 = 0.315).